Clara Jebet Sei is a Vice President and is responsible for leading Longhorn's vaccine and antibody development program and directs both local (U.S.) and global scientific projects geared towards the diagnosis, prevention, treatment and control of infectious diseases. For 20 years, she has held industry leadership positions and managed Phase 1 and 2b/3 clinical trials. Clara has a Master’s degree in Public Health from the George Washington University, Milken Institute School of Public Health, Washington D.C. (GWU) and is a Public Health doctorate candidate. She has a proven track record and oversees the establishment of laboratory facilities and manages logistic operations, and undertakes creative innovation including peer-reviewed publications and/or patents, scientific expertise, study design, regulatory compliance and strategic support of drug discovery and clinical programs. She has extensive experience in directing multiple diverse collaborations while working with world-class researchers and manages the administration and execution of NDAs, MTAs, and CRADAs, among others, between public (government/military) and/or private entities. Her broad experience in biotechnology and professional interests in global public health lends valuable contributions and dedication to the implementation of new molecular tools to build better diagnostics, develop safer and more effective vaccines, and improve immunologic therapeutics for the advancement of public health and medicine.